Physiological Roles of Carnitine/Organic Cation Transporter OCTN1/SLC22A4 in Neural Cells

被引:19
|
作者
Nakamichi, Noritaka [1 ]
Kato, Yukio [1 ]
机构
[1] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharm, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan
关键词
carnitine/organic cation transporter 1 (OCTN1); ergothioneine; neuron; neural stem cell; neurological disorder; ERGOTHIONEINE PROTECTS; FUNCTIONAL EXPRESSION; OXIDATIVE STRESS; IN-VITRO; DISEASE; NEUROGENESIS; IDENTIFICATION; INVOLVEMENT; SLC22A4; NEURONS;
D O I
10.1248/bpb.b17-00099
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dysfunction in neurotransmission mediated by neurotransmitters causes various neurological disorders. Therefore, receptors and reuptake transporters of neurotransmitters have been focused on as a therapeutic target in neurological disorders. These membrane proteins have high affinity for a specific neurotransmitter and are highly expressed on synaptic membranes. In contrast, xenobiotic transporters have relatively lower affinity for neurotransmitters but widely recognize various organic cations and/or anions and are also expressed in brain neurons. However, it has been largely unknown why such xenobiotic transporters are expressed in neurons that play a key role in signal transduction. We have therefore attempted to clarify the physiological roles of one such xenobiotic organic cation transporter (OCT) in neural cells with the aim of obtaining new insight into the treatment of neurological disorders. Carnitine/organic cation transporter OCTN1/SLC22A4 is functionally expressed in neurons and neural stem cells. In particular, OCTN1 is expressed at much higher levels compared with other OCTs in neural stem cells and positively regulates their differentiation into neurons. OCTN1 accepts the naturally occurring food-derived antioxidant ergothioneine (ERGO) as a good in vivo substrate. Because ERGO is highly distributed into the brain after oral ingestion, OCTN1 may contribute to the alleviation of oxidative stress and promotion of neuronal differentiation via the uptake of ERGO in the brain, perhaps abating symptoms of neurological disorders. In this review, we introduce current topics on the physiological roles of OCTs with a focus on OCTN1 in neural cells and discuss its possible application to the treatment of neurological disorders.
引用
收藏
页码:1146 / 1152
页数:7
相关论文
共 50 条
  • [1] Suppression of proliferation by carnitine/organic cation transporter OCTN1 (SLC22A4) in neural progenitor cells
    Ishimoto, T.
    JOURNAL OF NEUROCHEMISTRY, 2012, 123 : 15 - 15
  • [2] Functional expression of carnitine/organic cation transporter OCTN1 (SLC22A4) in mouse
    Nakamichi, Noritaka
    Sugiura, Tomoko
    Taguchi, Takayuki
    Shimizu, Takuya
    Wakayama, Tomohiko
    Iseki, Shoichi
    Tsuji, Akira
    Kato, Yukio
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 253P - 253P
  • [3] Involvement of Carnitine/Organic Cation Transporter OCTN1/SLC22A4 in Gastrointestinal Absorption of Metformin
    Nakamichi, Noritaka
    Shima, Hiroyo
    Asano, Satoshi
    Ishimoto, Takahiro
    Sugiura, Tomoko
    Matsubara, Kazuki
    Kusuhara, Hiroyuki
    Sugiyama, Yuichi
    Sai, Yoshimichi
    Miyamoto, Ken-Ichi
    Tsuji, Akira
    Kato, Yukio
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (09) : 3407 - 3417
  • [4] Effect of Cholesterol on the Organic Cation Transporter OCTN1 (SLC22A4)
    Pochini, Lorena
    Pappacoda, Gilda
    Galluccio, Michele
    Pastore, Francesco
    Scalise, Mariafrancesca
    Indiveri, Cesare
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [5] Gene knockout and metabolome analysis of carnitine/organic cation transporter OCTN1/SLC22A4
    Sugiura, Tomoko
    Nakamichi, Noritaka
    Kubo, Yoshiyuki
    Kato, Sayaka
    Soga, Tomoyoshi
    Tsuji, Akira
    Kato, Yukio
    DRUG METABOLISM REVIEWS, 2010, 42 : 299 - 299
  • [6] GASTROINTESTINAL ABSORPTION OF METFORMIN REGULATED BY CARNITINE/ORGANIC CATION TRANSPORTER OCTN1 (SLC22A4)
    Asano, Satoshi
    Nakamichi, Noritaka
    Shima, Hiroyo
    Matsubara, Kazuki
    Sugiura, Tomoko
    Kusuhara, Hiroyuki
    Sugiyama, Yuichi
    Sai, Yoshimichi
    Miyamoto, Ken-ichi
    Kato, Yukio
    DRUG METABOLISM REVIEWS, 2012, 44 : 135 - 135
  • [7] Functional analysis of carnitine/organic cation transporter OCTN1 (SLC22A4) expressed in mouse brain
    Nakamichi, Noritaka
    Taguchi, Takayuki
    Hosotani, Hiroshi
    Yamada, Hiroya
    Sugiura, Tomoko
    Kato, Yukio
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 119P - 119P
  • [8] Functional characterization of ergothioneine transport by rat organic cation/carnitine transporter OCTN1 (slc22a4)
    Nakamura, Toshimichi
    Yoshida, Kenji
    Yabuuchi, Hikaru
    Maeda, Tomoji
    Tamai, Ikumi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (08) : 1580 - 1584
  • [9] Functional Expression of Carnitine/Organic Cation Transporter OCTN1/SLC22A4 in Mouse Small Intestine and Liver
    Sugiura, Tomoko
    Kato, Sayaka
    Shimizu, Takuya
    Wakayama, Tomohiko
    Nakamichi, Noritaka
    Kubo, Yoshiyuki
    Iwata, Daisuke
    Suzuki, Kazuhiro
    Soga, Tomoyoshi
    Asano, Masahide
    Iseki, Shoichi
    Tamai, Ikumi
    Tsuji, Akira
    Kato, Yukio
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (10) : 1665 - 1672
  • [10] Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4)
    Urban, Thomas J.
    Yang, Chen
    Castro, Richard A.
    Taylor, Travis R.
    Huang, Conrad C.
    Stryke, Douglas
    Johns, Susan J.
    Kawamoto, Michiko
    Carlson, Elaine J.
    Ferrin, Thomas E.
    Burchard, Esteban G.
    Giacomini, Kathleen M.
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (09): : 773 - 782